Development of Multifunctional and Orally Active Cyclic Peptide Agonists of Opioid/Neuropeptide FF Receptors that Produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side Effects-Reference-Cited by-同舟云学术

Development of Multifunctional and Orally Active Cyclic Peptide Agonists of Opioid/Neuropeptide FF Receptors that Produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side Effects

Published:2021-09-01 Issue:18 Volume:64 Page:13394-13409
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhang Mengna¹,Xu Biao¹,Li Ning¹,Zhang Run¹,Zhang Qinqin¹,Shi Xuerui¹,Xu Kangtai²,Xiao Jian¹,Chen Dan¹,Niu Jiandong¹,Shi Yonghang¹,Fang Quan¹^ORCID

Affiliation:

1. Key Laboratory of Preclinical Study for New Drugs of Gansu Province, and Institute of Physiology, School of Basic Medical Sciences, Lanzhou University, 199 Donggang West Road, Lanzhou, Gansu Province 730000, PR China

2. School of Life Sciences, Lanzhou University, 222 Tianshui South Road, Lanzhou, Gansu Province 730000, PR China

Funder

National Natural Science Foundation of China

Gansu Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00694

Reference69 articles.

1. Management of perioperative pain in patients chronically consuming opioids